 BOULDER, Colo., June 18, 2020 GLOBE NEWSWIRE -- miRagen Therapeutics, Inc. MGEN, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the appointment of Lee Rauch as Chief Operating Officer, effective immediately. Ms. Rauch reports directly to President and Chief Executive Officer William S. Marshall, Ph.D., and is responsible for overseeing miRagens business development, licensing, partnerships, investor relations, corporate communications, intellectual property, and new product planning. 